{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:21:31Z","timestamp":1787973691481,"version":"build-2784847793"},"reference-count":72,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15357","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:58:27Z","timestamp":1761220707000},"page":"1-6","source":"Crossref","is-referenced-by-count":1,"title":["Brain metastasis of ovarian cancer &gt;20 years after initial diagnosis: A case report"],"prefix":"10.3892","volume":"31","author":[{"given":"Chihiro","family":"Ishizawa","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Radiology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Neriishi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Kambe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Showa General Hospital, Tokyo 187\u20118510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"key20251205105231_b1-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"key20251205105231_b2-ol-31-1-15357","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"key20251205105231_b3-ol-31-1-15357","first-page":"609","article-title":"Ovarian cancer: An overview","volume":"80","author":"Roett","year":"2009","journal-title":"Am Fam Physician"},{"key":"key20251205105231_b4-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1006\/gyno.1995.1134","article-title":"Brain metastases in epithelial ovarian carcinoma","volume":"57","author":"Geisler","year":"1995","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b5-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ygyno.2016.09.025","article-title":"Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)","volume":"143","author":"Marchetti","year":"2016","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b6-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.tjog.2020.07.015","article-title":"Brain metastasis from ovarian carcinoma: Analysis of eight cases from a single radiotherapy center","volume":"59","author":"Bahat","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"key":"key20251205105231_b7-ol-31-1-15357","first-page":"527453","article-title":"Brain metastases from ovarian carcinoma","volume":"2011","author":"Piura","year":"2011","journal-title":"ISRN Oncol"},{"key":"key20251205105231_b8-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-811161-1.00007-4","article-title":"Brain metastases: Neuroimaging","volume":"149","author":"Pope","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"key20251205105231_b9-ol-31-1-15357","article-title":"Survival analysis of ovarian cancer patients with distant metastasis after chemotherapy: A SEER-based study","volume":"15","author":"Cheng","year":"2023","journal-title":"Indian J Cancer"},{"key":"key20251205105231_b10-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2176\/nmc.48.57","article-title":"Treatment and prognosis of brain metastases from gynecological cancers","volume":"48","author":"Ogawa","year":"2008","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"key20251205105231_b11-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/1097-0142(197802)41:2<776::AID-CNCR2820410253>3.0.CO;2-E","article-title":"Central nervous system involvement by ovarian carcinoma: A complication of prolonged survivial with metastatic disease","volume":"41","author":"Mayer","year":"1978","journal-title":"Cancer"},{"key":"key20251205105231_b12-ol-31-1-15357","first-page":"746","article-title":"Central nervous system metastases in epithelial ovarian carcinoma","volume":"68","author":"Larson","year":"1986","journal-title":"Obstet Gynecol"},{"key":"key20251205105231_b13-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1200\/JCO.2002.20.4.982","article-title":"Epithelial ovarian cancer metastasizing to the brain: A late manifestation of the disease with an increasing incidence","volume":"20","author":"Kolomainen","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20251205105231_b14-ol-31-1-15357","first-page":"44","article-title":"Brain metastasis as a late manifestation of ovarian carcinoma","volume":"20","author":"Chen","year":"2011","journal-title":"Eur J Cancer Care (Engl)"},{"key":"key20251205105231_b15-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1471-0528.1981.tb01267.x","article-title":"Involvement of the central nervous system in patients with ovarian carcinoma","volume":"88","author":"Barker","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"key20251205105231_b16-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jso.2930240309","article-title":"Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: Effect of treatment and incidence of intracranial metastases","volume":"24","author":"Budd","year":"1983","journal-title":"J Surg Oncol"},{"key":"key20251205105231_b17-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/1097-0142(19861101)58:9<2066::AID-CNCR2820580917>3.0.CO;2-Q","article-title":"Involvement of the central nervous system by ovarian carcinoma","volume":"58","author":"Stein","year":"1986","journal-title":"Cancer"},{"key":"key20251205105231_b18-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/1097-0142(19871115)60:10<2559::AID-CNCR2820601035>3.0.CO;2-7","article-title":"Central nervous system metastases in epithelial ovarian carcinoma","volume":"60","author":"Dauplat","year":"1987","journal-title":"Cancer"},{"key":"key20251205105231_b19-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF00151224","article-title":"Brain metastases from ovarian cancer","volume":"5","author":"Ziegler","year":"1987","journal-title":"J Neurooncol"},{"key":"key20251205105231_b20-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0090-8258(88)90254-5","article-title":"Advanced carcinoma of the ovary with central nervous system relapse","volume":"30","author":"Ross","year":"1988","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b21-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0090-8258(89)90515-5","article-title":"Cerebral metastases in patients with ovarian cancer treated with chemotherapy","volume":"33","author":"Hardy","year":"1989","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b22-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0028-2243(90)90068-C","article-title":"Brain metastases in epithelial ovarian carcinoma; two case reports","volume":"36","author":"Piura","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key20251205105231_b23-ol-31-1-15357","first-page":"278","article-title":"Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous system","volume":"75","author":"Plaxe","year":"1990","journal-title":"Obstet Gynecol"},{"key":"key20251205105231_b24-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/1097-0142(19910415)67:8<2194::AID-CNCR2820670832>3.0.CO;2-#","article-title":"Cerebral metastases from ovarian carcinoma","volume":"67","author":"LeRoux","year":"1991","journal-title":"Cancer"},{"key":"key20251205105231_b25-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1200\/JCO.1992.10.10.1553","article-title":"Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery","volume":"10","author":"Rodriguez","year":"1992","journal-title":"J Clin Oncol"},{"key":"key20251205105231_b26-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/gyno.1993.1082","article-title":"Cerebral metastases secondary to ovarian cancer: Still an unusual event","volume":"49","author":"Bruzzone","year":"1993","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b27-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01051051","article-title":"Solitary cerebral metastasis from ovarian carcinoma: Report of 4 cases","volume":"19","author":"Salvati","year":"1994","journal-title":"J Neurooncol"},{"key":"key20251205105231_b28-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/oxfordjournals.annonc.a059246","article-title":"Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review","volume":"6","author":"Cormio","year":"1995","journal-title":"Ann Oncol"},{"key":"key20251205105231_b29-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1006\/gyno.1999.5476","article-title":"A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment","volume":"74","author":"Suzuki","year":"1999","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b30-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1046\/j.1525-1438.2000.010005366.x","article-title":"Brain metastases from epithelial ovarian carcinoma","volume":"10","author":"Kaminsky-Forrett","year":"2000","journal-title":"Int J Gynecol Cancer"},{"key":"key20251205105231_b31-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/crad.2001.0965","article-title":"Cerebral metastasis and other cerebral events in women with ovarian cancer","volume":"57","author":"Sanderson","year":"2002","journal-title":"Clin Radiol"},{"key":"key20251205105231_b32-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/gyno.2002.6653","article-title":"Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases","volume":"85","author":"Anupol","year":"2002","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b33-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/gyno.2002.6792","article-title":"Craniotomy for central nervous system metastases in epithelial ovarian carcinoma","volume":"87","author":"Pothuri","year":"2002","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b34-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/107327480301000309","article-title":"Central nervous system metastases from primary epithelial ovarian cancer","volume":"10","author":"Kumar","year":"2003","journal-title":"Cancer Control"},{"key":"key20251205105231_b35-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/B:NEON.0000014516.04943.38","article-title":"Brain metastases in patients with ovarian carcinoma: Prognostic factors and outcome","volume":"66","author":"Cohen","year":"2004","journal-title":"J Neurooncol"},{"key":"key20251205105231_b36-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1111\/j.1525-1438.2005.00143.x","article-title":"Brain metastases from epithelial ovarian cancer","volume":"15","author":"Tay","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"key20251205105231_b37-ol-31-1-15357","first-page":"3553","article-title":"Brain metastases from epithelial ovarian cancer. The Hellenic cooperative oncology group (HeCOG) experience and review of the literature","volume":"25","author":"Pectasides","year":"2005","journal-title":"Anticancer Res"},{"key":"key20251205105231_b38-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10143-004-0363-4","article-title":"Solitary cerebral metastases from ovarian epithelial carcinoma: 11 cases","volume":"28","author":"D'Andrea","year":"2005","journal-title":"Neurosurg Rev"},{"key":"key20251205105231_b39-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/cncr.21472","article-title":"Use of the radiation therapy oncology group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma","volume":"104","author":"Chen","year":"2005","journal-title":"Cancer"},{"key":"key20251205105231_b40-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/ijgc-00009577-200605000-00007","article-title":"Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy","volume":"16","author":"Kastritis","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"key20251205105231_b41-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/j.1525-1438.2007.00941.x","article-title":"Prognostic factors associated with brain metastases from epithelial ovarian carcinoma","volume":"17","author":"Kim","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"key20251205105231_b42-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ygyno.2007.11.027","article-title":"Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer","volume":"108","author":"Lee","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b43-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/annonc\/mdq229","article-title":"Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: Results of a German multicenter study","volume":"21","author":"Sehouli","year":"2010","journal-title":"Ann Oncol"},{"key":"key20251205105231_b44-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ijgo.2011.02.014","article-title":"Changes in the management and outcome of central nervous system involvement from ovarian cancer since 1994","volume":"114","author":"Cormio","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"key20251205105231_b45-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000494334","article-title":"Survival impact of optimal surgical cytoreduction in recurrent epithelial ovarian cancer with brain metastasis","volume":"42","author":"Keskin","year":"2019","journal-title":"Oncol Res Treat"},{"key":"key20251205105231_b46-ol-31-1-15357","first-page":"4403","article-title":"Brain recurrences in patients with ovarian cancer: Report of 12 cases and review of the literature","volume":"27","author":"Gadducci","year":"2007","journal-title":"Anticancer Res"},{"key":"key20251205105231_b47-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"873198","DOI":"10.3389\/fonc.2022.873198","article-title":"Successful treatment of a patient with brain metastasis from ovarian cancer with BRCA wild type using niraparib: A case report and review of the literature","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"key20251205105231_b48-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/oxfordjournals.annonc.a058736","article-title":"Paclitaxel (Taxol) concentrations in brain tumor tissue","volume":"5","author":"Heimans","year":"1994","journal-title":"Ann Oncol"},{"key":"key20251205105231_b49-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/cncr.22450","article-title":"Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis","volume":"109","author":"Fortin","year":"2007","journal-title":"Cancer"},{"key":"key20251205105231_b50-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1756-9966-31-53","article-title":"Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?","volume":"31","author":"Takano","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"key20251205105231_b51-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/gyno.1993.1117","article-title":"Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages","volume":"49","author":"O'Brien","year":"1993","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b52-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The gynecologic oncology group experience","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol"},{"key":"key20251205105231_b53-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b54-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1159\/000065067","article-title":"Mechanisms of cisplatin resistance in clear cell carcinoma of the ovary","volume":"62","author":"Itamochi","year":"2002","journal-title":"Oncology"},{"key":"key20251205105231_b55-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1349-7006.2008.00747.x","article-title":"Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma","volume":"99","author":"Itamochi","year":"2008","journal-title":"Cancer Sci"},{"key":"key20251205105231_b56-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s13256-023-04211-6","article-title":"Cerebellar metastasis of ovarian cancer: A case report","volume":"17","author":"Cabitza","year":"2023","journal-title":"J Med Case Rep"},{"key":"key20251205105231_b57-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.3390\/jcm12072497","article-title":"Description of a retrospective cohort of epithelial ovarian cancer patients with brain metastases: Evaluation of the role of PARP inhibitors in this setting","volume":"12","author":"Alizzi","year":"2023","journal-title":"J Clin Med"},{"key":"key20251205105231_b58-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"37080","DOI":"10.18632\/oncotarget.26354","article-title":"A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models","volume":"9","author":"Sun","year":"2018","journal-title":"Oncotarget"},{"key":"key20251205105231_b59-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"818","DOI":"10.21037\/apm-21-113","article-title":"Successful treatment of a patient with brain metastases from endometrial cancer using Niraparib: A case report","volume":"10","author":"Wang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"key20251205105231_b60-ol-31-1-15357","first-page":"e61355","article-title":"Niraparib maintenance therapy for brain metastasis in ovarian endometrioid adenocarcinoma with peritoneal carcinomatosis: A comprehensive case study and literature review","volume":"16","author":"Proskuriakova","year":"2024","journal-title":"Cureus"},{"key":"key20251205105231_b61-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"512","DOI":"10.6004\/jnccn.2024.0052","article-title":"NCCN Guidelines\u00ae insights: Ovarian cancer\/fallopian tube cancer\/primary peritoneal cancer, version 3.2024","volume":"22","author":"Liu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20251205105231_b62-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/cells9071651","article-title":"CSC radioresistance: A therapeutic challenge to improve radiotherapy effectiveness in cancer","volume":"9","author":"Olivares-Urbano","year":"2020","journal-title":"Cells"},{"key":"key20251205105231_b63-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-016-2210-5","article-title":"Effects of radiation on metastasis and tumor cell migration","volume":"73","author":"Vilalta","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"key20251205105231_b64-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1158\/0008-5472.CAN-17-0524","article-title":"Radiotherapy-Activated cancer-associated fibroblasts promote tumor progression through paracrine igf1r activation","volume":"78","author":"Tommelein","year":"2018","journal-title":"Cancer Res"},{"key":"key20251205105231_b65-ol-31-1-15357","first-page":"2793","article-title":"Brain metastases from epithelial ovarian cancer: Overview and optimal management","volume":"29","author":"Pietzner","year":"2009","journal-title":"Anticancer Res"},{"key":"key20251205105231_b66-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/cas.14754","article-title":"Establishment and implementation of cancer genomic medicine in Japan","volume":"112","author":"Mukai","year":"2021","journal-title":"Cancer Sci"},{"key":"key20251205105231_b67-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10147-020-01831-6","article-title":"Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)","volume":"26","author":"Naito","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"key20251205105231_b68-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10147-017-1137-7","article-title":"Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance","volume":"22","author":"Oda","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"key20251205105231_b69-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.22.01549","article-title":"Overall survival with maintenance olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: The SOLO1\/GOG 3004 trial","volume":"41","author":"DiSilvestro","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20251205105231_b70-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13048-016-0259-2","article-title":"Genomic alterations in neuroendocrine cancers of the ovary","volume":"9","author":"Yaghmour","year":"2016","journal-title":"J Ovarian Res"},{"key":"key20251205105231_b71-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ygyno.2018.07.013","article-title":"Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials","volume":"150","author":"Meagher","year":"2018","journal-title":"Gynecol Oncol"},{"key":"key20251205105231_b72-ol-31-1-15357","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/mgg3.414","article-title":"Next-generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug-resistant recurrent ovarian cancer","volume":"6","author":"Du","year":"2018","journal-title":"Mol Genet Genomic Med"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:52:39Z","timestamp":1764924759000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,23]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15357","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}